<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7906073</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4424</journal-id>
<journal-id journal-id-type="nlm-ta">J Affect Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Affect Disord</journal-id>
<journal-title-group>
<journal-title>Journal of affective disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">0165-0327</issn>
<issn pub-type="epub">1573-2517</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30219690</article-id>
<article-id pub-id-type="pmc">6186181</article-id>
<article-id pub-id-type="doi">10.1016/j.jad.2018.09.003</article-id>
<article-id pub-id-type="manuscript">NIHMS1506884</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GWAS and Systems Biology Analysis of Depressive Symptoms among Smokers from the COPDGene Cohort</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Heinzman</surname>
<given-names>Jonathan T.</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoth</surname>
<given-names>Karin F.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Michael H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sakornsakolpat</surname>
<given-names>Phuwanat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Regan</surname>
<given-names>Elizabeth A.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Make</surname>
<given-names>Barry J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kinney</surname>
<given-names>Gregory L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wamboldt</surname>
<given-names>Frederick S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holm</surname>
<given-names>Kristen E.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bormann</surname>
<given-names>Nicholas</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robles</surname>
<given-names>Julian</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Victor</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iyer</surname>
<given-names>Anand S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silverman</surname>
<given-names>Edwin K.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crapo</surname>
<given-names>James D.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Shizhong</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Potash</surname>
<given-names>James B.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shinozaki</surname>
<given-names>Gen</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<on-behalf-of>on behalf of the COPDGene Investigators</on-behalf-of>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA</aff>
<aff id="A2"><label>2</label>Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA, USA</aff>
<aff id="A3"><label>3</label>Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MA, USA</aff>
<aff id="A4"><label>4</label>Department of Medicine, National Jewish Health, Denver, CO, USA</aff>
<aff id="A5"><label>5</label>Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO, USA</aff>
<aff id="A6"><label>6</label>Department of Psychiatry, University of Colorado School of Medicine at the Anschutz Medical Campus, Aurora, CO, USA</aff>
<aff id="A7"><label>7</label>Department of Thoracic Medicine and Surgery, Temple University School of Medicine, Philadelphia, PA, USA</aff>
<aff id="A8"><label>8</label>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A9"><label>9</label>Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A10"><label>10</label>Health Services, Outcomes, and Effectiveness Research Training Program, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A11"><label>11</label>Department of Psychiatry, Johns Hopkins University, Baltimore, MD, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Contributors</p>
<p id="P2">JTH contributed to the data analysis and interpretation, and manuscript drafting. KFH, EAR, ASI, BJM GLK and KEH contributed to the design, data acquisition and manuscript drafting. MHC contributed to the data analysis, interpretation and manuscript drafting. FSW, VK and CHM contributed to data interpretation. NB and JR contributed to data analysis. VK, ASI, CHM contributed to data acquisition and interpretation. EKS and JDC contributed to the overall design of the COPDGene study and data acquisition, interpretation, and manuscript drafting. SH developed GLITTER and contributed to data analysis and interpretation. JBP contributed to the design and data interpretation. GS contributed to the overall design of this specific analysis, data acquisition, interpretation, and manuscript drafting. All authors commented on and approved the final manuscript.</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author:</bold> Gen Shinozaki, MD, University of Iowa Hospitals and Clinics, Medical Laboratories, 25 South Grand Avenue, c/o B002FE, Iowa City, IA 52242, Phone: (319) 384-4932, Fax: (319) 353-4568, <email>gen-shinozaki@uiowa.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P40">Competing Financial Interests</p>
<p id="P41">COPD Foundation Funding: The COPDGene® project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Siemens and Sunovion.</p>
<p id="P42">Gen Shinozaki has disclosed a conflict of interest as a founder of Predelix Medical LLC, although it has no relationship to this manuscript. All other authors have declared no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>243</volume>
<fpage>16</fpage>
<lpage>22</lpage>
<!--elocation-id from pubmed: 10.1016/j.jad.2018.09.003-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P3">Large sample GWAS is needed to identify genetic factors associated with depression. This study used genome-wide genotypic and phenotypic data from the COPDGene study to identify genetic risk factors for depression.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P4">Data were from 9,716 COPDGene subjects with ≥ 10 pack-year history. Depression was defined as antidepressant use and/or a HADS depression subscale score ≥ 8. Non-Hispanic White (6,576) and African-American (3,140) subsets were analyzed. A GWAS pipeline identified SNPs associated with depression in each group. Network analysis software analyzed gene interactions through common biological pathways, genetic interactions, and tissue-specific gene expression.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P5">The mean age was 59.4 years (SD 9.0) with 46.5% female subjects. Depression was in 24.7% of the NHW group (1,622) and 12.5% of the AA group (391). No SNPs had genome-wide significance. One of the top SNPs, rs12036147 (p=1.28 × 10<sup>−6</sup>), is near CHRM3. Another SNP was near MDGA2 (rs17118176, p=3.52 × 10<sup>−6</sup>). Top genes formed networks for synaptic transmission with statistically significant level of more co-expression in brain than other tissues, particularly in the basal ganglia (p=1.00 × 10<sup>−4</sup>).</p>
</sec>
<sec id="S4">
<title>Limitations:</title>
<p id="P6">Limitations included a depression definition based on antidepressant use and a limited HADS score subgroup, which could increase false negatives in depressed patients not on antidepressants. Antidepressants used for smoking cessation in non-depressed patients could lead to false positives.</p>
</sec>
<sec id="S5">
<title>Conclusions:</title>
<p id="P7">Systems biology analysis identified statistically significant pathways whereby multiple genes influence depression. The gene set pathway analysis and COPDGene data can help investigate depression in future studies.</p>
</sec>
</abstract>
<kwd-group>
<kwd>major depressive disorder</kwd>
<kwd>systems biology</kwd>
<kwd>chronic obstructive pulmonary disease</kwd>
<kwd>smokers</kwd>
<kwd>genome-wide association study</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>